A Phase 1 Study of Neratinib in Combination With Temsirolimus in Subjects With Solid Tumours.

Trial Profile

A Phase 1 Study of Neratinib in Combination With Temsirolimus in Subjects With Solid Tumours.

Completed
Phase of Trial: Phase I

Latest Information Update: 28 Nov 2016

At a glance

  • Drugs Neratinib (Primary) ; Temsirolimus
  • Indications Advanced breast cancer; Colorectal cancer; Gynaecological cancer; Non-small cell lung cancer; Pancreatic cancer; Solid tumours; Thymoma; Vulvovaginal cancer
  • Focus Adverse reactions
  • Sponsors Pfizer; Puma Biotechnology
  • Most Recent Events

    • 09 Dec 2013 Results published in the Journal of Clinical Oncology.
    • 01 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 07 May 2012 Company added as trial sponsor and additional lead trial centre identified as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top